Supplementation with excess folate can inhibit the degradation of MAT2A through the ubiquitin protein transferase VCIP135, indirectly accelerating the methionine cycle in cancer tissues, and promoting the progression of HCC [61]. The gene discussed is MAT2A; the disease is hepatocellular carcinoma.